{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T00:07:03Z","timestamp":1768003623802,"version":"3.49.0"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,1,26]],"date-time":"2013-01-26T00:00:00Z","timestamp":1359158400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Psychopharmacology"],"published-print":{"date-parts":[[2013,5]]},"DOI":"10.1007\/s00213-013-2975-2","type":"journal-article","created":{"date-parts":[[2013,1,25]],"date-time":"2013-01-25T05:08:27Z","timestamp":1359090507000},"page":"347-354","source":"Crossref","is-referenced-by-count":20,"title":["Role of gamma-aminobutyric acid type A (GABAA) receptor subtypes in acute benzodiazepine physical dependence-like effects: evidence from squirrel monkeys responding under a schedule of food presentation"],"prefix":"10.1007","volume":"227","author":[{"given":"Bradford D.","family":"Fischer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura P.","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael L.","family":"van Linn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ojas A.","family":"Namjoshi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James K.","family":"Rowlett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,1,26]]},"reference":[{"key":"2975_CR1","first-page":"483","volume":"253","author":"JU Adams","year":"1990","unstructured":"Adams JU, Holtzman SG (1990) Pharmacologic characterization of the sensitization to the rate-decreasing effects of naltrexone induced by acute opioid pretreatment in rats. J Pharmacol Exp Ther 253:483\u2013489","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR2","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1124\/jpet.105.089920","volume":"316","author":"JR Atack","year":"2006","unstructured":"Atack JR, Wafford KA, Tye SJ, Cook SM, Sohal B, Pike A, Sur C, Melillo D, Bristow L, Bromidge F, Ragan I, Kerby J, Street L, Carling R, Castro JL, Whiting P, Dawson GR, McKernan RM (2006) TPA023 [7-(1,1 dimethylethyl)-6-(2-ethyl-2H-1,2,4-triazol-3-ylmethoxy)-3-(2-fluorophenyl)-1,2,4-triazolo[4,3-b]pyridazine], an agonist selective for alpha2- and alpha3-containing GABAA receptors, is a nonsedating anxiolytic in rodents and primates. J Pharmacol Exp Ther 316:410\u2013422","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR3","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0091-3057(94)90543-6","volume":"48","author":"ME Bronson","year":"1994","unstructured":"Bronson ME (1994) Chlordiazepoxide, but not bretazenil, produces acute dependence, as evidenced by disruptions in schedule-controlled behavior. Pharmacol Biochem Behav 48:397\u2013401","journal-title":"Pharmacol Biochem Behav"},{"key":"2975_CR4","doi-asserted-by":"crossref","first-page":"5572","DOI":"10.1523\/JNEUROSCI.22-13-05572.2002","volume":"22","author":"N Collinson","year":"2002","unstructured":"Collinson N, Kuenzi FM, Jarolimek W, Maubach KA, Cothliff R, Sur C, Smith A, Otu FM, Howell O, Atack JR, McKernan RM, Seabrook GR, Dawson GR, Whiting PJ, Rosahl TW (2002) Enhanced learning and memory and altered GABAergic synaptic transmission in mice lacking the alpha 5 subunit of the GABAA receptor. J Neurosci 22:5572\u20135580","journal-title":"J Neurosci"},{"key":"2975_CR5","doi-asserted-by":"crossref","first-page":"8980","DOI":"10.1073\/pnas.142288699","volume":"99","author":"F Crestani","year":"2002","unstructured":"Crestani F, Keist R, Fritschy JM, Benke D, Vogt K, Prut L, Bl\u00fcthmann H, M\u00f6hler H, Rudolph U (2002) Trace fear conditioning involves hippocampal alpha5 GABAA receptors. Proc Natl Acad Sci U S A 99:8980\u20138985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2975_CR6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S0091-3057(00)00176-3","volume":"66","author":"EE Elliot","year":"2000","unstructured":"Elliot EE, White JM (2000) Precipitated and spontaneous withdrawal following administration of lorazepam but not zolpidem. Pharmacol Biochem Behav 66:361\u2013369","journal-title":"Pharmacol Biochem Behav"},{"key":"2975_CR7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.neuropharm.2010.08.011","volume":"59","author":"BD Fischer","year":"2010","unstructured":"Fischer BD, Licata SC, Edwankar RV, Wang ZJ, Huang S, He X, Yu J, Zhou H, Johnson EM Jr, Cook JM, Furtm\u00fcller R, Ramerstorfer J, Sieghart W, Roth BL, Majumder S, Rowlett JK (2010) Anxiolytic-like effects of 8-acetylene imidazobenzodiazepines in a rhesus monkey conflict procedure. Neuropharmacology 59:612\u2013618","journal-title":"Neuropharmacology"},{"key":"2975_CR8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1007\/s002130050266","volume":"131","author":"LR Gerak","year":"1997","unstructured":"Gerak LR, France CP (1997) Repeated administration of flumazenil does not alter its potency in modifying schedule-controlled behavior in chlordiazepoxide treated rhesus monkeys. Psychopharmacology 131:64\u201370","journal-title":"Psychopharmacology"},{"key":"2975_CR9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s002130050422","volume":"134","author":"RR Griffiths","year":"1997","unstructured":"Griffiths RR, Weerts EM (1997) Benzodiazepine self-administration in humans and laboratory animals\u2014implications for problems of long-term use and abuse. Psychopharmacology 134:1\u201337","journal-title":"Psychopharmacology"},{"key":"2975_CR10","first-page":"1199","volume":"260","author":"RR Griffiths","year":"1992","unstructured":"Griffiths RR, Sannerud CA, Ator NA, Brady JV (1992) Zolpidem behavioral pharmacology in baboons: self-injection, discrimination, tolerance and withdrawal. J Pharmacol Exp Ther 260:1199\u20131208","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR11","doi-asserted-by":"crossref","first-page":"3765","DOI":"10.1523\/JNEUROSCI.22-09-03765.2002","volume":"22","author":"SC Harvey","year":"2002","unstructured":"Harvey SC, Foster KL, McKay PF, Carroll MR, Seyoum R, Woods JE 2nd, Grey C, Jones CM, McCane S, Cummings R, Mason D, Ma C, Cook JM, June HL (2002) The GABAA receptor alpha1 subtype in the ventral pallidum regulates alcohol-seeking behaviors. J Neurosci 22:3765\u20133775","journal-title":"J Neurosci"},{"key":"2975_CR12","doi-asserted-by":"crossref","first-page":"865","DOI":"10.2165\/00003495-200059040-00014","volume":"59","author":"KJ Holm","year":"2000","unstructured":"Holm KJ, Goa KL (2000) Zolpidem: an update of its pharmacology, therapeutic efficacity and tolerability in the treatment of insomnia. Drugs 59:865\u2013889","journal-title":"Drugs"},{"key":"2975_CR13","first-page":"528","volume":"184","author":"SG Holtzman","year":"1973","unstructured":"Holtzman SG, Villarreal JE (1973) Operant behavior in the morphine-dependent rhesus monkey. J Pharmacol Exp Ther 184:528\u2013541","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR14","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.brainres.2004.02.040","volume":"1009","author":"CL Kliethermes","year":"2004","unstructured":"Kliethermes CL, Metten P, Belknap JK, Buck KJ, Crabbe JC (2004) Selection for pentobarbital withdrawal severity: correlated differences in withdrawal from other sedative drugs. Brain Res 1009:17\u201325","journal-title":"Brain Res"},{"key":"2975_CR15","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nature06493","volume":"451","author":"J Knabl","year":"2008","unstructured":"Knabl J, Witschi R, H\u00f6sl K, Reinold H, Zeilhofer UB, Ahmadi S, Brockhaus J, Sergejeva M, Hess A, Brune K, Fritschy J-M, Rudolph U, M\u00f6hler H, Zeilhofer HU (2008) Reversal of pathological pain through specific spinal GABAA receptor subtypes. Nature 451:330\u2013334","journal-title":"Nature"},{"key":"2975_CR16","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1124\/jpet.104.081612","volume":"313","author":"SC Licata","year":"2005","unstructured":"Licata SC, Platt DM, Cook JM, Sarma PV, Griebel G, Rowlett JK (2005) Contribution of GABAA receptor subtypes to the anxiolytic-like, motor, and discriminative stimulus effects of benzodiazepines: studies with the functionally selective ligand SL651498 [6-fluoro-9-methyl-2-phenyl-4-(pyrrolidin-1-yl-carbonyl)-2,9-dihydro-1H-pyridol[3,4-b]indol-1-one]. J Pharmacol Exp Ther 313:1118\u20131125","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR17","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.pbb.2008.01.001","volume":"90","author":"SC Licata","year":"2008","unstructured":"Licata SC, Rowlett JK (2008) Abuse and dependence liability of benzodiazepine-type drugs: GABAA receptor modulation and beyond. Pharmacol Biochem Behav 90:74\u201389","journal-title":"Pharmacol Biochem Behav"},{"key":"2975_CR18","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1126\/science.290.5489.131","volume":"290","author":"K L\u00f6w","year":"2000","unstructured":"L\u00f6w K, Crestani F, Keist R, Benke D, Brunig I, Benson JA, Fritschy JM, Rulicke T, Bluethmann H, Mohler H, Rudolph U (2000) Molecular and neuronal substrate for the selective attenuation of anxiety. Science 290:131\u2013134","journal-title":"Science"},{"key":"2975_CR19","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1126\/science.6287579","volume":"217","author":"SE Lukas","year":"1982","unstructured":"Lukas SE, Griffiths RR (1982) Precipitated withdrawal by a benzodiazepine receptor antagonist (Ro 15\u20131788) after 7 days of diazepam. Science 217:1161\u20131163","journal-title":"Science"},{"key":"2975_CR20","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/0014-2999(84)90218-8","volume":"100","author":"SE Lukas","year":"1984","unstructured":"Lukas SE, Griffiths RR (1984) Precipitated diazepam withdrawal in baboons: effects of dose and duration of diazepam exposure. Eur J Pharmacol 100:163\u2013171","journal-title":"Eur J Pharmacol"},{"key":"2975_CR21","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/75761","volume":"3","author":"RM McKernan","year":"2000","unstructured":"McKernan RM, Rosahl TW, Reynolds DS, Sur C, Wafford KA, Atack JR, Farrar S, Myers J, Cook G, Ferris P, Garrett L, Bristow L, Marshall G, Macaulay A, Brown N, Howell O, Moore KW, Carling RW, Street LJ, Castro JL, Ragan CI, Dawson GR, Whiting PJ (2000) Sedative but not anxiolytic properties of benzodiazepines are mediated by the GABAA receptor \u03b11 subtype. Nat Neurosci 3:587\u2013592","journal-title":"Nat Neurosci"},{"key":"2975_CR22","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1124\/jpet.300.3.1017","volume":"300","author":"LR McMahon","year":"2002","unstructured":"McMahon LR, France CP (2002) Daily treatment with diazepam differentially modifies sensitivity to the effects of gamma-aminobutyric acid(A) modulators on schedule-controlled responding in rhesus monkeys. J Pharmacol Exp Ther 300:1017\u20131025","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR23","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1124\/jpet.105.094474","volume":"316","author":"NR Mirza","year":"2006","unstructured":"Mirza NR, Nielsen E\u00d8 (2006) Do subtype-selective gamma-aminobutyric acid A receptor modulators have a reduced propensity to induce physical dependence in mice? J Pharmacol Exp Ther 316:1378\u20131385","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1124\/pr.108.00505","volume":"60","author":"RW Olsen","year":"2008","unstructured":"Olsen RW, Sieghart W (2008) International Union of Pharmacology. LXX. Subtypes of gamma-aminobutyric acid(A) receptors: classification on the basis of subunit composition, pharmacology, and function. Update. Pharmacol Rev 60:243\u2013260","journal-title":"Pharmacol Rev"},{"key":"2975_CR25","first-page":"1222","volume":"290","author":"CA Paronis","year":"1999","unstructured":"Paronis CA, Bergman J (1999) Apparent pA2 values of benzodiazepine antagonists and partial agonists in monkeys. J Pharmacol Exp Ther 290:1222\u20131229","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR26","first-page":"298","volume":"263","author":"G Perrault","year":"1992","unstructured":"Perrault G, Morel E, Sanger DJ, Zivkovic B (1992) Lack of tolerance and physical dependence upon repeated treatment with the novel hypnotic zolpidem. J Pharmacol Exp Ther 263:298\u2013303","journal-title":"J Pharmacol Exp Ther"},{"key":"2975_CR27","unstructured":"Platt DM, Carey G, Spealman RD (2011). Models of neurological disease (substance abuse): self-administration in monkeys. Curr Protoc Pharmacol. Chapter 10:Unit10.5"},{"key":"2975_CR28","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1126\/science.2551039","volume":"245","author":"DB Pritchett","year":"1989","unstructured":"Pritchett DB, L\u00fcddens H, Seeburg PH (1989) Type I and type II GABAA-benzodiazepine receptors produced in transfected cells. Science 245:1389\u20131392","journal-title":"Science"},{"key":"2975_CR29","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1073\/pnas.0405621102","volume":"102","author":"JK Rowlett","year":"2005","unstructured":"Rowlett JK, Platt DM, Lelas S, Atack JR, Dawson GR (2005) Different GABAA receptor subtypes mediate the anxiolytic, abuse-related, and motor effects of benzodiazepine-like drugs in primates. Proc Natl Acad Sci U S A 102:915\u2013920","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2975_CR30","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/44579","volume":"401","author":"U Rudolph","year":"1999","unstructured":"Rudolph U, Crestani F, Benke D, Brunig I, Benson JA, Fritschy JM, Martin JR, Bluethmann H, Mohler H (1999) Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature 401:796\u2013800","journal-title":"Nature"},{"key":"2975_CR31","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/S0165-6147(00)01646-1","volume":"22","author":"U Rudolph","year":"2001","unstructured":"Rudolph U, Crestani F, M\u00f6hler H (2001) GABAA receptor subtypes: dissecting their pharmacological functions. Trends Pharmacol Sci 22:188\u2013194","journal-title":"Trends Pharmacol Sci"},{"key":"2975_CR32","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.pnpbp.2010.01.004","volume":"34","author":"MM Savi\u0107","year":"2010","unstructured":"Savi\u0107 MM, Majumder S, Huang S, Edwankar RV, Furtm\u00fcller R, Joksimovi\u0107 S, Clayton T Sr, Ramerstorfer J, Milinkovi\u0107 MM, Roth BL, Sieghart W, Cook JM (2010) Novel positive allosteric modulators of GABAA receptors: do subtle differences in activity at alpha1 plus alpha5 versus alpha2 plus alpha3 subunits account for dissimilarities in behavioral effects in rats? Prog Neuropsychopharmacol Biol Psychiatry 34:376\u2013386","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"2975_CR33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1124\/mol.59.5.1108","volume":"59","author":"AJ Smith","year":"2001","unstructured":"Smith AJ, Alder L, Silk J, Adkins C, Fletcher AE, Scales T, Kerby J, Marshall G, Wafford KA, McKernan RM, Atack JR (2001) Effect of \u03b1 subunit on allosteric modulation of ion channel function in stably expressed human recombinant \u03b3 aminobutyric acidA receptors determined using 36Cl ion flux. Mol Pharmacol 59:1108\u20131118","journal-title":"Mol Pharmacol"},{"key":"2975_CR34","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/BF00180845","volume":"88","author":"RD Spealman","year":"1986","unstructured":"Spealman RD (1986) Disruption of schedule-controlled behavior by Ro 15\u20131788 one day after acute treatment with benzodiazepines. Psychopharmacology 88:398\u2013400","journal-title":"Psychopharmacology"},{"key":"2975_CR35","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nature08758","volume":"463","author":"KR Tan","year":"2010","unstructured":"Tan KR, Brown M, Labou\u00e8be G, Yvon C, Creton C, Fritschy JM, Rudolph U, L\u00fcscher C (2010) Neural bases for addictive properties of benzodiazepines. Nature 463:769\u2013774","journal-title":"Nature"},{"key":"2975_CR36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s002130051066","volume":"145","author":"KE Vanover","year":"1999","unstructured":"Vanover KE, Robledo S, Huber M, Carter RB (1999) Pharmacological evaluation of a modified conflict procedure: punished drinking in non-water-deprived rats. Psychopharmacology (Berl) 145:333\u2013341","journal-title":"Psychopharmacology (Berl)"},{"key":"2975_CR37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1111\/j.1365-2125.2007.02861.x","volume":"64","author":"C Victorri-Vigneau","year":"2007","unstructured":"Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P (2007) Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64:198\u2013209","journal-title":"Br J Clin Pharmacol"},{"key":"2975_CR38","first-page":"285","volume":"9","author":"EM Weerts","year":"1998","unstructured":"Weerts EM, Griffiths RR (1998) Zolpidem self-injection with concurrent physical dependence under conditions of long-term continuous availability in baboons. Behav Pharmacol 9:285\u2013297","journal-title":"Behav Pharmacol"}],"container-title":["Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-2975-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00213-013-2975-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00213-013-2975-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,8]],"date-time":"2019-07-08T18:07:28Z","timestamp":1562609248000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00213-013-2975-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,1,26]]},"references-count":38,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,5]]}},"alternative-id":["2975"],"URL":"https:\/\/doi.org\/10.1007\/s00213-013-2975-2","relation":{},"ISSN":["0033-3158","1432-2072"],"issn-type":[{"value":"0033-3158","type":"print"},{"value":"1432-2072","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,1,26]]}}}